AMP-activated protein kinase (AMPK) is a master cellular energy sensor that has received much attention as a promising therapeutic target for obesity-associated metabolic disorders, including NAFLD/NASH8–11. The gene discussed is PRKAA1; the disease is obesity due to melanocortin 4 receptor deficiency.